Risk of gastric cancer after Roux-en-Y gastric bypass

Archives of Surgery

Volumn 142, Issue 10, 2007, Pages 947-953

  Inoue, Harutaka ^a,d   Rubino, Francesco ^a,c,e   Shimada, Yutaka ^d   Lindner, Véronique ^b   Inoue, Masako ^a   Riegel, Philippe ^a   Marescaux, Jacques ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b HÔPITAL CIVIL   (France)

^c CATHOLIC UNIVERSITY   (Italy)

^d KYOTO UNIVERSITY   (Japan)

^e Institute de Recherche contra les Cancers de l'Appareil Digestif   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CARCINOGEN; METHYLNITROSOUREA; TAP WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BILE REFLUX; BILIRUBIN BLOOD LEVEL; CANCER CENTER; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; EXPERIMENTAL MODEL; INTESTINE FLORA; NONHUMAN; OBESITY; PATHOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; ROUX Y ANASTOMOSIS; SHAM FEEDING; STOMACH; STOMACH BYPASS; STOMACH CANCER; STOMACH CONTENT;

ANIMALS; BILIRUBIN; DISEASE MODELS, ANIMAL; GASTRIC BYPASS; GASTRIC JUICE; GASTRIC STUMP; MALE; RATS; RATS, INBRED F344; RISK ASSESSMENT; STOMACH NEOPLASMS;

EID: 35348986492     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.142.10.947     Document Type: Article

References (27)

1. Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004;291 (23):2847-2850.
2. Kluthe R, Schubert A. Obesity in Europe. Ann Intern Med. 1985;103(6, pt 2): 1037-1042.
3. Steinbrook R. Surgery for severe obesity. N Engl J Med. 2004;350(11):1075-1079.
4. Higa KD, Ho T. Laparoscopic Roux-en-Y gastric bypass: technique and 3-year follow-up. J Laparoendosc Adv Surg Tech A. 2001;11(6):377-382.
5. Raijman I, Strother SV, Donegan WL. Gastric cancer after gastric bypass for obesity: case report. J Clin Gastroenterol. 1991;13(2):191-194.
6. Lord RV, Edwards PD, Coleman MJ. Gastric cancer in the bypassed segment after operation for morbid obesity: case report. Aust N Z J Surg. 1997;67(8): 580-582.
7. Khitin L, Roses RE, Birkett DH. Cancer in the gastric remnant after gastric bypass: a case report. Curr Surg. 2003;60(5):521-523.
8. Escalona A, Guzman S, Ibanez L. Gastric cancer after Roux-en-Y gastric bypass. Obes Surg. 2005;15(3):423-427.
9. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000: the global picture. Eur J Cancer. 2001;37(suppl 8):S4-S66.
10. Kamineni A, Williams MA, Schwartz SM, Cook LS, Weiss NS. The incidence of gastric carcinoma in Asian migrants to the United States and their descendants. Cancer Causes Control. 1999;10(1):77-83.
11. Schafer LW, Larson DE, Melton LJ III, Higgins JA, Ilstrup DM. The risk of gastric carcinoma after surgical treatment for benign ulcer disease: a population-based study in Olmsted County, Minnesota. N Engl J Med. 1983;309(20):1210-1213.
12. Caygill CP, Hill MJ, Kirkham JS, Northfield TC. Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet. 1986;1(8487):929-931.
13. Langhans P, Heger RA, Hohenstein J, Bunte H. Gastric stump carcinoma: new aspects deduced from experimental results. Scand J Gastroenterol Suppl. 1981; (67):161-164.
14. Koestner AW, Ruecker FA, Koestner A. Morphology and pathogenesis of tumors of the thymus and stomach in Sprague-Dawley rats following intragastric administration of methyl nitrosourea (MNU). Int J Cancer. 1977;20(3):418-426.
15. Hirota N, Aonuma T, Yamada S, Kawai T, Saito K, Yokoyama T. Selective induction of glandular stomach carcinoma in F344 rats by N-methyl-N-nitrosourea. Jpn J Cancer Res. 1987;78(7):634-638.
16. Xu Y, Ohinata K, Meguid MM, et al. Gastric bypass model in the obese rat to study metabolic mechanisms of weight loss. J Surg Res. 2002;107(1):56-63.
17. Ramos EJ, Xu Y, Romanova I, et al. Is obesity an inflammatory disease? Surgery. 2003;134(2):329-335.
18. Meguid MM, Ramos EJ, Suzuki S, et al. A surgical rat model of human Rouxen-Y gastric bypass. J Gastrointest Surg. 2004;8(5):621-630.
19. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239(1):1-11.
20. Rubino F, Zizzari P, Tomasetto C, et al. The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat. Endocrinology. 2005;146(4):1745-1751.
21. Hill MJ. Bacterial N-nitrosation and gastric carcinogenesis in humans. Ital J Gastroenterol. 1991;23(1):17-23.
22. Iijima K, Grant J, McElroy K, Fyfe V, Preston T, McColl KE. Novel mechanism of nitrosative stress from dietary nitrate with relevance to gastro-oesophageal junction cancers. Carcinogenesis. 2003;24(12):1951- 1960.
23. Deng D, Xin H. Formation of N-(nitrosomethyl)urea in stomachs of experimental pigs and human volunteers given fish sauce in vivo. J Agric Food Chem. 2000; 48(6):2495-2498.
24. Sen NP, Seaman SW, Baddoo PA, Burgess C, Weber D. Formation of N-nitroso-N-methylurea in various samples of smoked/dried fish, fish sauce, seafoods, and ethnic fermented/pickled vegetables following incubation with nitrite under acidic conditions. J Agric Food Chem. 2001;49(4):2096-2103.
25. Imaida K, Fukushima S, Shirai T, Masui T, Ogiso T, Ito N. Promoting activities of butylated hydroxyanisole, butylated hydroxytoluene and sodium L-ascorbate on forestomach and urinary bladder carcinogenesis initiated with methylnitrosourea in F344 male rats. Gann. 1984;75(9):769-775.
26. Lax AJ. Opinion: Bacterial toxins and cancer: a case to answer? Nat Rev Microbiol. 2005;3(4):343-349.
27. Lee WJ, Wang W. Bariatric surgery: Asia-Pacific perspective. Obes Surg. 2005; 15(6):751-757.